Hironori Koga

21PUBLICATIONS
17CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 01, 2026
Claudin-2 extracellular loop 1-mimetic peptides functionally inhibit combined hepatocellular-cholangiocarcinoma cells.

|Oct 25, 2024
Efficacy of Atezolizumab Plus Bevacizumab-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.

Etsuko Moriyama, Shigeo Shimose, Takashi Niizeki

|Sep 06, 2024
Leucine drives LAT1-related SNAIL upregulation in glucose-starved pancreatic cancer cells.

Hajime Masubuchi, Yasuko Imamura, Takumi Kawaguchi

|Sep 28, 2023
Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score Matching.

Shigeo Shimose, Hideki Iwamoto, Takashi Niizeki

|Aug 08, 2023
Anti-PD-L1 antibodies promote cellular proliferation by activating the PD-L1-AXL signal relay in liver cancer cells.

Toshimitsu Tanaka, Hironori Koga, Hiroyuki Suzuki

|Apr 16, 2023
The impact of curative conversion therapy aimed at a cancer-free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Shigeo Shimose, Hideki Iwamoto, Tomotake Shirono

Pageof 4

Frequent Collaborators

11 joint publications

Masahito Nakano

11 joint publications

Shigeo Shimose

8 joint publications

Tomotake Shirono

7 joint publications

Takumi Kawaguchi